Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trade Dress Changes May Interfere With Intellectual Property Protection

This article was originally published in The Tan Sheet

Executive Summary

A change in a product's trade dress as a result of the OTC labeling final rule requirements would violate intellectual property protection by restricting product distinctiveness, attorney Charles Buffon, Covington & Burling, asserted at an FDA working group on the OTC labeling reg in Rockville, Md. Aug. 24.

You may also be interested in...



Off-Package Labeling For Small Cosmetic-Drugs Suggested By CTFA

Off-package labeling of inactive ingredients for small, cartonless cosmetic-drug products should be allowed as a general exemption to FDA's OTC labeling final rule, the Cosmetic, Toiletry & Fragrance Association suggested during an agency-industry workshop in Rockville, Md. Sept. 17.

Off-Package Labeling For Small Cosmetic-Drugs Suggested By CTFA

Off-package labeling of inactive ingredients for small, cartonless cosmetic-drug products should be allowed as a general exemption to FDA's OTC labeling final rule, the Cosmetic, Toiletry & Fragrance Association suggested during an agency-industry workshop in Rockville, Md. Sept. 17.

Off-Package Labeling For Small Cosmetic-Drugs Suggested By CTFA

Off-package labeling of inactive ingredients for small, cartonless cosmetic-drug products should be allowed as a general exemption to FDA's OTC labeling final rule, the Cosmetic, Toiletry & Fragrance Association suggested during an agency-industry workshop in Rockville, Md. Sept. 17.

Topics

UsernamePublicRestriction

Register

ID005817

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel